A CLINICAL STUDY OF GOMUTRA BHAVITA LEKHANIYA MAHAKASHAYA IN THE MANAGEMENT OF OBESITY

Similar documents
An International Journal of Research in AYUSH and Allied Systems. Research Article

DEPARTMENT OF KAYACHIKITSA J. S. AYURVEDA COLLEGE, NADIAD

OBESITY IN PRIMARY CARE

International Journal of Applied Ayurved Research ISSN: EFFICACY OF DEODARVYADI CHURNA WITH ARAND OIL IN LUMBAR SPONDYLOSIS 1 Damle D Neena,

Clinical Evaluation Of Asana Kashay In Sthaulya W.S.R. To Obesity

International Journal of Ayurveda and Pharma Research

Greentree Group Publishers

TOTAL FITNESS and WELLNESS. Exercise, Diet, and Weight Control

INTERNATIONAL AYURVEDIC MEDICAL JOURNAL. Anita A. Patil. Associate professor, Panchakarma Department,

Atherogenic Index as a Predictor of Cardiovascular Risk among Women with Different Grades of Obesity

Obesity D R. A I S H A H A L I E K H Z A I M Y

THE EFFECT OF DIET AND LIFESTYLE ON TREATMENT WITH GUDUCHYADI

Study the etiopathogenesis of hyperlipidaemia and action of lekhaniya mahakashaya vati.

International Journal of Ayurveda and Pharma Research

Science of Obesity (I-2.28)

Statement of Objectives:

Professional Diploma. in Nutrition. Module 1. Lesson 1: Health is Your Wealth EQF Level 5. Professional Diploma

Clinical Study Reports (Uncontrolled studies)

Understanding Body Composition

Plasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension

Rick Fox M.A Health and Wellness Specialist

World Journal of Pharmaceutical Research SJIF Impact Factor 7.523

Management Ayurvedic of Hyperlipedemia: A Case Report Prasad Kulkarni 1 *, Vishwas Gogate 2 and Pramod Patil 3

PIJAR SANDHIGATAVATA WITH SPECIAL REFERENCE TO OSTEOARTHRITIS AND MANAGEMENT WITH RASNADI GUGGULU AND GUDUCHYADI KASHAYA -A CLINICAL ANALYSIS.

overweight you are part of it!... Healthier, fitter, safer... Seafarers Health Information Programme ICSW S.H.I.P.

The Paleolithic Diet. A Review

Obesity. Picture on. This is the era of the expanding waistline.

BCH 445 Biochemistry of nutrition Dr. Mohamed Saad Daoud

Table Classification of body mass index (BMI) and risk of comorbidities in adults (WHO, 1998; WHO Expert Consultation,

Overweight. You are part of it! Healthier, fitter, safer.

The Clinical Study on the Management of Sthula Madhumeha by Herbal Drugs

ADDRESSING CHRONIC DISEASES

STHAULYA A CONCEPTUALIZED STUDY A REVIEW

Journal of Pharmaceutical and Scientific Innovation

Module 2: Metabolic Syndrome & Sarcopenia. Lori Kennedy Inc & Beyond

Pharmacological Study of Padm-Keshar (Nelumbo nucifera) on Dysfunctional Uterine Bleeding (DUB)

Body Mass Index and Waist Hip Ratio among Youth of India

INTERNATIONAL AYURVEDIC MEDICAL JOURNAL

EVALUATION OF EFFECT OF PUNARNAVA GHANVATI IN PRAMEHA UPDARVA WITH SPECIAL REFERANCE TO DIABETIC NEPHROPATHY

Lecture 7 Body Composition Lecture 7 1. What is Body Composition? 2. Healthy Body Weight 3. Body Fat Distribution 4. What Affects Weight Gain?

Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes. Stephen D. Sisson MD

Part 1: Obesity. Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes 10/15/2018. Objectives.

A comparative study on the fasting and post prandial lipid levels as a cardiovascular risk factor in patients with type 2 diabetes mellitus

BMI. Summary: Chapter 7: Body Weight and Body Composition. Obesity Trends

A NIDANATMAKA (EPIDEMIOLOGICAL) STUDY ON MUTRASHMARI

Lecture 7 Body Composition Lecture 7 1. What is Body Composition? 2. Healthy Body Weight 3. Body Fat Distribution 4. What Affects Weight Gain?

International Journal of Ayurvedic and Herbal Medicine 7:2(2017)

Efficacy of Vamana followed by Nyagrodadi Churna in the management of sthula madhumeha (NIDDM)

Efficacy of 'Shunthyadi Kwath ' in Amavata.

PUNARNAVA Boerhavia diffusa Linn

UNDERSTANDING PEM IN AYURVEDA WITH MANAGEMENT

What Is Body Composition?

A study of waist hip ratio in identifying cardiovascular risk factors at Government Dharmapuri College Hospital

Energy balance. Factors affecting energy input. Energy input vs. Energy output Balance Negative: weight loss Positive: weight gain

Manipal & Apollo Spectra Hospital. Special Interest:Laparoscopy & Bariatric Surgery

PIEDMONT ACCESS TO HEALTH SERVICES, INC. Guidelines for Screening and Management of Dyslipidemia

Body Weight and Body Composition

INTERNATIONAL JOURNAL OF AYURVEDA & ALTERNATIVE MEDICINE

A clinical study on the role of herbal compound belfaladi churna in the management of atisaar

Research Article International Ayurvedic Medical Journal ISSN: JIAR, Jammu, India ABSTRACT

P.G.Institute Indore (M.P.) 2 Associate Professor Dept.of Samhita Siddhant, Shubhdeep Ayurved Medical College,

ROLE OF NITYA VIRECHANA IN MEDOROGA - A CASE STUDY

Role of Dhatryadi Rasakriya Anjana in Refractive errors

Heart Health. Team Member Workbook Session 1 LEARN IDENTIFY ACT. Learn about HTHU Level 3 and the point system

Chapter 18. Diet and Health

ARE YOU OBESE?! Aaser Abdelazim

A CLINICAL OBSERVATION ON THE EFFECT OF COLLAGEN HYDROLYSATE (Calorad*) ON OVERWEIGHT AND OBESE INDIVIDUALS

Stress Induced IBS and its Ayurvedic Management- A Case Study Urja Singh 1 * and Akhilesh Shrivastava 2

Energy balance. Factors affecting energy input. Energy input vs. Energy output Balance Negative: weight loss Positive: weight gain

HEALTH MANAGEMENT PLAN PROGRAMME

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF AMALAKI CHURNA IN LEU- CORRHOEA

ISSN: CASE STUDY OF GREEVA

OVERVIEW OF NUTRITION & HEALTH

Supplementary Online Content. Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and

Goals 1/9/2018. Obesity over the last decade Surgery has become a safer management strategy Surgical options for management

Effective Interventions in the Clinical Setting: Engaging and Empowering Patients. Michael J. Bloch, M.D. Doina Kulick, M.D.

International Journal of Ayurveda and Pharma Research

International Journal of Pharma and Bio Sciences COMPARISON OF EFFICACY AND SAFETY OF RIMONABANT WITH ORLISTAT IN OBESE AND OVERWEIGHT PATIENTS

Patient Group Direction for the Supply of Orlistat (Xenical) from Designated Community Pharmacies

Know Your Numbers. Your guide to maintaining good health. Helpful information from Providence Medical Center and Saint John Hospital

Strategies in Weight Management

Your Name & Phone Number Here! Longevity Index

Weight Loss Surgery Program

Healthy Weight and Body Image. Chapter 6

What is overweight and obesity, causes and consequences

Obesity Causes Complications and Dietary Weight Loss Strategy

Keeping a Healthy Weight & Nutrition Guidelines. Mrs. Anthony

Honey and Cinnamon Interesting Drug Combination!!!

A CLINICAL STUDY ON THE EFFECT OF DASANGA GUGGULU IN THE MANAGEMENT OF MEDO ROGA WITH SPECIAL REFERENCE TO HYPERLIPIDEMIA

Test5, Here is Your My5 to Health Profile with Metabolic Syndrome Insight

Obesity. Assist. Prof. Ivana Kolčić

A CLINICAL STUDY ON THE CONCEPT OF KARNANADA &KARNAKSHVED WITH SPECIAL REFFERENCEE TO TINNITUS

Aerobic Exercise Improves Lipid Levels of Normal and Obese Subjects

Also, some risk factors, such as smoking and diabetes, put you at greater risk for CHD and heart attack than others.

International Journal of Multidisciplinary Research Review, Vol.1, Issue - 16, June Page - 1

Greentree Group Publishers

Selected Overweight- and Obesity- Related Health Disorders

Activity Overview. Bottle Bodies: Measuring Body Fat Activity 3A. Corpulosity. Activity Objectives: Activity Description: Activity Background:

STUDY OF DARBARI KANADAA RAGA AS A MANSO ANUGUNA SHABDA CHIKITSA IN THE MANAGEMENT OF NIDRANASHA w.s.r. TO INSOMNIA

New Patient Information

Transcription:

INTERNATIONAL AYURVEDIC MEDICAL JOURNAL International Ayurvedic Medical Journal, (ISSN: 23 5091) (March, 17) 5 (3) A CLINICAL STUDY OF GOMUTRA BHAVITA LEKHANIYA MAHAKASHAYA IN THE MANAGEMENT OF OBESITY Ramawtar Sharma 1, Bharat Sharma 2 1 BAMS, MD (Kayachikitsa) 2 BAMS Chirayu Ayurveda and Panchkarma Hospital, Ajmer, Rajasthan, India Email: dr.ram85@gmail.com ABSTRACT Obesity is the world`s oldest metabolic disorder. The WHO now considers obesity to be a global epidemic and public health problem. Globally an estimated 300 million adults are now obese and many are overweight. Overweight and obesity are defined as abnormal or excessive fat accumulation of body that presents a risk to health. A person with a BMI of 30 or more is generally considered obese. The problem is due to calorie imbalance resulting from an excessive food intake coupled with inadequate exercise. Prominent health risks associated with obesity are hypertension, DM type2, dyslipidemia, stroke, gallbladder stone, and O.A. respiratory problems. As per Ayurveda, acharyacharaka has counted sthoulya under the eight varieties of impediments which are designated as Ninditapurusha. According to Chikitsa sutra of the disease, lekhniya therapy is an important therapeutic measure in sthoulyas said by Acharya Charaka. Moreover, drugs of lekhaniyamahakashaya are most effective in the management of sthoulya. To assess the effect of lekhan therapy patients were selected for this study from the OPD of Chirayu Ayurveda and Panchkarma hospital, Ajmer, Rajasthan. The effect of the therapy was assessed statically based on the performa prepared. Key words: lekhaniyamahakashya, sthoulya, obesity INTRODUCTION Obesity is defined as body weight above a desirable standard as a result of lack of physiof food. A cal activity with increased intake BMI of 25 to 29.9 kg per m2 is defined as overweight. A BMI of 30 kg per m2 or more is defined as obesity. These conditions result from a problem of imbalance between energy intake and expenditure. Obesity is not a new problem it is also described in Ayurvedic literature as well. [1] [2] [3]. Causative factors of obesity are lack of exercise, sleeping day time ( Diwa swapa), ex- (sweet),snigdha cessive eating of madhura (oily), sheeta (cold) food, bijadosha (genetic causes) [2].Due to these factors fat metabolism of human body get disturbed i.e. Medo dhat-

wagni mandya, leads to excessive deposition of fat in body leads to obesity. In the past few years there has been a dramatic increase in obesity and obesity related health hazards. At present in India about 30 million Indians are obes e. It is predicted to double in the next 5 years. Easy access to high-calorie packaged foods, consumption of more calories than one can burn out by exercise, lack of exercise, sedentary lifestyles have resulted in almost 70% Indians in megacities such as Mumbai, Delhi, Bangalore or Chennai being overweight or obese. Obese individuals are at increased risk of morbidity/mortality from type 2 diabetes, hypertension, coronary artery disease (CAD), cancer (partic u- larly colon, prostate, and breast cancer), sleep apnoea, degenerative joint disease, thromboembolic disorders, and dermatologic disorders [4]. In modern medicine Pharmacological treatment for obesity are having side effects [5] [6] like drug interfere with the absorption of fat soluble vitamins like A, D, E, K. Other treatment such as Liposuction, Bariatric surgery, which are costly and with many risk factors [6]. Clinically Ayurvedic medicines are found to be useful in weight reduction. Patients suffering from obesity blindly use Ayurvedic tablets, Herbal tea like products marketed on TV sky shops, News paper and magazine advertisements, without doctor s consultation. These medicines may prove harmful for their health. Lekhaniya kashaya [7] is collection of Herbs having properties which are useful for reduction of fat without interfering digestion and absorption of vitamins. Lekhaniya Kashaya also improves overall digestion as well as fat metabolism of patient due to its penetrating hot properties (ushna tikshna guna). AIMS AND OBJECTIVES To study the proper etiopathogenesis of sthoulya according to ayurveda and modern medicine. To assess the effect of gomutra bhavita lekhaniya mahahkashaya in the management of sthoulya. STUDY DESIGN- Total patients were enrolled in this trial. Freshly prepared Gomutra bhavita Lekhaniya mahakashaya was given in churna form twice a day before food for 2 months. Clinical and statistical assessment of enrolled patients was done monthly, for two months. INCLUSION CRITERIA: (1) Men and Women of 18 year to 65 year of age were enrolled in the project. (2) Patients with BMI more than 30 were enrolled in the project BMI values can categorize patients into three classes of obesity: BMI is calculated by using formula =Body Weight (kg)/ Height (m) 2 Overweight BMI = 25-29.9 Class I (mild obesity) BMI = 30.0 to 34.9 kg/m2 Class II (moderate obesity) BMI = 35.0 to 39.9 kg/m2 Class III (severe obesity) BMI 40 kg/m2 (3) Measurement of waist circumference = waist circumference >40 inches (>102 cm) in men and >35 inches (>88 cm) in women were enrolled in this project. (4) In this trial apple shaped as well as pear shaped obsessed patients were enrolled. To decide patient was having which type of obesity following formula was used. IAMJ: MARCH, 17 663

Measurement of waist at narrowest point Waist to Hip ratio = ------------------------------- --------------------------- Measurement of Hip circumference at widest point Hip waist ratio more than 0.90 in male and more than 0.80 in females is associated with increased risk of heart disease, Diabetes Mellitus. So health risks of overweight and obesity are associated with excess abdominal fat i.e. apple shaped obesity. (5) Patients who had obesity associated with Hypothyroidism were in inclusion of the project with required dose of thyroxin. (6) Patients who had obesity associated with both weight bearing joint pain were also included in the project. (7) Patients who had obesity with k/c/o Hyperlipidemia were also included in the project. (8) Patients who had obesity with k/c/o Non- Insulin dependent Diabetes Mellitus were in inclusion of the project with required dose of hypoglycemic drugs. Exclusion Criteria: 1) Patients with k/c/o Cushing's syndrome 2) Patients on corticosteroids 3) Bedridden or wheelchair confined patients 4) History of gastrointestinal bleeding. 5) Patients with history of gastric and Duodenal ulcer 6) Patients with acid peptic disease 7) Pregnant or nursing women ASSESSMENT CRITERIA: In this project enrolled patients were assessed on the basis of pre and post observations. OBJECTIVE CRITERIA: BMI of the patient before and after treatment. Patient s weight before and after treatment. Waist circumference of patients before and after treatment. Waist to Hip ratio of patients. DRUG PROFILE- The lekhaniya mahakashaya is described in Charak Samhita. This mahakashaya contain 10 drugs namely-mustak, kustha, haridra, daruharidra, vacha, ativisha, kutki, chitrak, chirbilva and hemvati. Due to unavailability of hemvati, shuddh guggulu is taken in place of hemvati in this trial. Fresh gomutra was taken from a nearby dairy for the bhavna process. All 10 drugs of the lekhaniya mahakashaya were taken in equal quantity as churna form. Bhavna of fresh gomutra in this churna was given for three times. After preparing the homogenous mixture the paste was dried to make fine powder. ADMINISTRATION OF THE DRUG- Gomuta bhavita lekhaniya mahakashaya churna was given in the dose of 2gms BD with the anupan of luke warm water for two months. OBSERVATION Statistical Analysis: H01: No significant effect of the treatment i.e. LEKHANIYA KASHAYA in weight reduction H11: Significant effect of the treatment in weight reduction. Decision Criterion: Reject H01 if t cal>t tab at 5% l.o.s. As t cal = 10.60 > t tab =2.26, we reject H01 and say that the treatment is effective in weight reduction. IAMJ: MARCH, 17 664

H02: No significant effect of the treatment i.e. LEKHANIYA KASHAYA in BMI reduction H12: Significant effect of the treatment in BMI reduction. Decision Criterion: Reject H02 if t cal> t tab at 5% l.o.s. As t cal = 10.77 > t tab =2.26, we reject H02 and say that the treatment is effective in BMI Reduction. H03: No significant effect of the treatment i.e. LEKHANIYA KASHAYA in WAIST CIR- CUMFERENCE reduction H13: Significant effect of the treatment in WAIST CIRCUMFER- ENCE reduction. Decision Criterion: Reject H03 if t cal> t tab at 5% l.o.s. As t cal = 6.38 > t tab =2.26, we reject H03 and say that the treatment is effective in BMI reduction. STATICAL OBSERVATION- Total numbers of patients (16 female and 4 male patients) were enrolled in the project. Male patient had Hip waist ratio more than 0.90. Out of 9 enrolled females, 10 had Hip waist ratio more than 0.80 (60%females had Hip waist ratio more than 0.80) and6 females had Hip waist ratio less than 0.80.(30% females had Hip waist ratio less than 0.80) Mean SD SE T Remark Weight 3.5 1.49 0.47 10.6 Significant 5% level of significance(p<0.05) BMI 1.64 0.6 0.19 10.77 Significant 5% level of significance(p<0.05) Waist circumference 1.35 0.67 0.21 6.38 Significant 5% level of significance(p<0.05) BMI of enrolled patients Among enrolled patients 12 patients had BMI between 30.0 to 34.9 kg/m 2, 6 patients had BMI between 35.0 to 39.9 kg/m 2 and 2 patients had BMI 40 kg/m 2. Changes seen in weight before and after treatment Reduction of weight 50 40 wt. in kg 30 10 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Series1 Series2 No. of patients IAMJ: MARCH, 17 665

Changes in BMI patients before and after treatment Changes seen in BMI of patients BT and AT 50 40 BMI 30 10 Series1 Series2 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 No. of patients Changes seen in waist circumference before and after treatment Waist circumference inches 50 40 30 10 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 no. of patients Other Observations: All 100% patients enrolled in the trail were consuming vegetarian diet. % of total enrolled patients were having obesity with Hypothyroidism. 70% of total enrolled patients were having obesity with both knee joint pain (weight bearing joint pain due to excessive weight) % of total enrolled patients were having obesity with Hyperlipidemia. Total 50% of all enrolled patients were hav- ing symptom Dyspnoea on exertion. IAMJ: MARCH, 17 Observation of Other benefits after 2 months of therapy: Lightness in body Reduction in lethargy Reduction in edema Reduction in LDL,VLDL total Cholesterol levels (% of total enrolled patients who was k/c/o obesity with Hyperlipidemia reduced their LDL, VLDL, Triglaeceride level up to 25% in 2 months) Improvement in HDL cholesterol level (% of total enrolled patients who was k/c/o obe- 666

sity with Hyperlipidemia improved their HDL cholesterol level up to 30% in 2 months) Reduction in weight bearing joint (Knee joint) pain-70 % of total enrolled patients who was having obesity with both knee joint pain (weight bearing joint pain due to excessive weight) showed 50% improvement in knee joint pain and 30% improvement after 2 months of treatment. Patients with known cases of obesity with hypothyroidism showed 25% improvement in levels of thyroid hormone. Also showed 50% improvement in reduction of symptoms like facial puffiness, agnimandya (loss of appetite), and menstrual disturbances, lethargy. PROBABLE MODE OF ACTION OF LEKHANIYA MAHAKASHAYA The properties of lekhaniya mahakashaya are katu, tikta, ras and having laghu, ruksha, tikshana, lekhan guna, katu vipak and ushana veerya, kaphavatashamak. By this lekhan and medohara action, the quantity of abadha meda reduced from the dependable parts of the body, which brought laghuta, and relief in chalatva. Though the udipta jatharagni get pacified, so ksudhadhikya diminished. Sweda is the mala of the meda, so reduction of the meda inhibits excess sweating. Due to deepan pachan properties of lekhaniya mahakashaya, nutrients get digested and dhatu poshakansha can easily reach to respective dhatus enhancing the proper nutrition to all dhatus. So it seems that the above combination not only acts on symptomatology of the disease but also checks its progression by hiting the basic pathological process i.e. medovaha strotosang and meda Sanchaya. CONCLUSION Lekhaniya mahakashaya is doing lekhan of excessive fat (reducing excessive fat) due to its ushna, tikshna, lekhan (penetrating hot) properties. So it is useful in obesity. Lekhaniyakashaya is significantly reducing weight, BMI and waist circumference at 5% level of significance (p < 0.05). Lekhaniya Kashaya didn t develop any major side effects in patients after 2 months of therapy. In this project only 2 months therapy was given, but we can continue Lekhaniya Kashaya for extra period for more weight reduction, which is the further scope of study. During trial it was observed that Lekhaniya Kashaya was beneficial in reducing total cholesterol level, LDL levels, and VLDL levels. It also showed benefits like improvement in thyroid hormone levels and reduction in symptoms of Hypothyroidism. It showed good improvement in menstrual disturbances. REFERENCES 1. Charak Samhita based on Chakrapani Datta s Ayurveda Dipika,Auther name Dr. Ram- Karam Sharma and Vaidya Bhagwan Dash, Reprint edition 07,Published by Chaukhamba Sanskrita Series,Volume II, Charak- Vimansthan Chapter 5 SrotoViman, Shloka number 16,page number 178 2. Charak Samhita based on Chakrapani Datta s Ayurveda Dipika, Author name Dr. Ram Karam Sharma and Vaidya Bhagwan Dash, Reprint edition 07,Published by Chaukhamba Sanskrita Series,Volume I,Charak Sutrasthan Chapter 21 Astauniditiyayhyaya, Shloka number 4,page number 375 IAMJ: MARCH, 17 667

3. MadhavNidan by Vijayaraksita and Shrikanthadattaand extracts from Atankadarpana by Vachaspati Vaidya, Edited by Vaidya Yadavji Tricumji Acharya, Publisher Chaukhamba Orientalia, Reprint edition 10 Chapter 34 Medoroga Nidanam, page no 226, shloka no 1,2 ) 4. Ferries Clinical Adviser Instant Diagnosis and Treatment, 09 edition, Author FRED F. FERRI -Printed in United States of America, ISBN No-978-0-323-04134-8, e-library copy, Website www.mdconsult.com., Section- I Disease and Disorders,Chaper name Obesity. 5. ACP Medicine ((American college of Phys i- cians Medicine) by David C. Dale and Daniel D. Federman,3rd edition 07,Section III-- Chapter no. 10, e- copy, Website - www.acpmedicine.com 6. API Textbook of medicine 7th edition, of India, Section VIII-Metabolism Chapter 06 Disorders of Adipose tissue and Obesity chapter written by Dr.Shashank Joshi, page number 264 7. Charak Samhita based on ChakrapaniDatta s Ayurveda Dipika,Author name Dr.Ram Karam Sharma and Vaidya Bhagwan- Dash,Reprint edition 07,Published by Chaukhamba Sanskrita Series,VolumeI,CharakSutrasthan Chapter 4 Sadvirechanasatasritiyadhya, Shloka number 8,page number 88 Source of Support: Nil Conflict Of Interest: None Declared How to cite this URL: Ramawtar Sharma1, Bharat Sharma2a Clinical Study Of Gomutra Bhavita Lekhaniya Mahakashaya In The Management Of Obesity. International Ayurvedic Medical Journal {online} 17 {cited March, 17} Available from: http://www.iamj.in/posts/images/upload/662_668.pdf IAMJ: MARCH, 17 668